Whooping Cough: Symptoms, Treatment, Prevention & Red Flags

Pertussis is a person-to-person infection limited to humans, transmitted by large droplets and close aerosol contact with respiratory secretions containing B. pertussis. After a 7–10 day incubation (range roughly 5–21 days), bacteria adhere to ciliated respiratory epithelium and elaborate pertussis toxin plus other adhesins and toxins that disrupt mucociliary clearance, provoke lymphocytic infiltration and generate the prolonged cough syndrome that can extend beyond 10 weeks—hence the lay term “100-day cough.”

Clinical severity is inversely related to age and immunisation gaps: older children and adults experience nuisance cough and occasional rib fracture or syncope, whereas neonates face apnea, pulmonary hypertension, secondary bacterial pneumonia and death. Waning vaccine-induced immunity explains ongoing circulation despite high childhood coverage, making adolescents and adults important silent reservoirs for household transmission to infants.

For nursing practice the operational construct is not memorising every virulence factor but recognising phase-dependent infectiousness, prioritising diagnostic sampling before antibiotics when feasible, pairing respiratory isolation with structured monitoring of work of breathing and feeding, and escalating early when apnea or hypoxia appears in a young infant.

Mapping the patient onto the phase ladder guides testing yield, isolation duration and counselling on expected cough duration.

↔On a small screen, swipe or scroll sideways to see the full table.

Typical older child or adult: coryzal prodrome followed by paroxysms, inspiratory whoop (not universal), post-tussive emesis, normal chest examination between spells.

Neonate / young infant: apnea or bradycardia spells, gagging, cyanosis, minimal cough; may present with sepsis-like picture.

Atypical: vaccinated partial immunity may truncate whoop and shorten catarrhal phase yet still permit transmission—maintain suspicion in clustered cough outbreaks.

B. pertussis is the principal agent; B. parapertussis causes a milder syndrome and may not be covered by all vaccine antigens—mention when PCR panels return atypical patterns. Risk concentrates in household clusters, maternity settings, undervaccinated communities and any prolonged face-to-face contact during the catarrhal phase.

Chronic cough from tuberculosis or other causes can coexist in high-burden regions—use travel, HIV and contact history to avoid anchoring prematurely on pertussis alone.

Clinical assessment

Ask about cough paroxysms, post-tussive vomiting, whoop, apnea in infants, known exposures and vaccine/ antibiotic history. Perform lung auscultation to exclude focal pneumonia.

Laboratory investigations

• Nasopharyngeal swab or aspirate for PCR/NAAT—gold standard in practice; sensitivity time-limited.
• CBC—absolute lymphocytosis supports diagnosis in classic age groups.
• Serology may assist late presenters in some centres—interpret with laboratory advice.

Imaging

Not routine; consider chest radiograph if hypoxia, focal signs or concern for pneumonia.

1. Suspect compatible cough + exposure or lymphocytosis in a classic host.
2. Isolate droplet precautions and collect NAAT before macrolide if delay is clinically safe.
3. Treat with macrolide when case probable or confirmed; start empirically in severe infant while awaiting PCR if advised locally.
4. Trace household and high-risk contacts; initiate PEP per public-health algorithm.
5. Monitor spell counts, SpO₂, feeding, work of breathing—admit infants with any instability.

• Pneumonia as superinfection—new focal signs, sustained fever or rising oxygen requirement; imaging and cultures guide antibiotics.
• Influenza and other viral URIs—shorter prodrome, systemic myalgia, rapid antigen/PCR panels.
• RSV infection—wheeze and crackles more prominent; seasonal clustering.
• Mycoplasma or bronchitis—lacks classic post-tussive emesis cluster; PCR panels help.
• Asthma exacerbation—bronchodilator responsive; eosinophilic history.

First-line antimicrobial therapy for confirmed or strongly suspected pertussis remains a macrolide—commonly five days of azithromycin in modern paediatric and adult pathways, with erythromycin or clarithromycin alternatives where formulary or pregnancy dictates. Treatment shortens bacterial shedding but does not abruptly abort established paroxysms; set family expectations accordingly.

Special populations: neonates often need inpatient observation even after first doses; pregnant patients require obstetric coordination; severe renal or hepatic impairment demands pharmacist-guided dosing. Macrolide-resistant isolates are geographically clustered—if culture returns resistance, hand over to infectious diseases for non-macrolide salvage guided by sensitivities.

Supportive care: small frequent feeds, nasal suction, oxygen, head-up positioning and occasionally suction-assisted airway management in PICU. Avoid sedating antitussives routinely in infants.

Recheck spell counts and vital signs every 4–8 hours on inpatient wards; move to continuous monitoring if apnea documented. Repeat CBC only when clinical trajectory changes. Review macrolide tolerability (GI upset, QT vigilance on telemetry when risk factors exist) at 48–72 hours. Discharge when feeding stable, spells rare and home oxygen not required—usually coordinated with paediatrics.

Document vaccine status, chemoprophylaxis offered and occupational-health clearance for staff before sign-off. Communicate with schools or employers only through agreed public-health channels.

• Secondary bacterial pneumonia, pneumothorax, rib fracture from forceful cough.
• Hypoxic brain injury from prolonged apnea in neonates.
• Pulmonary hypertension in severe infant disease—managed in tertiary PICU.

Primary series (DTaP) plus adolescent/adult Tdap boosters reduce incidence but do not eliminate carriage windows—counsel families on cocooning around newborns. Chemoprophylaxis for contacts follows jurisdiction-specific algorithms. Healthcare workers should maintain up-to-date Tdap and adhere to work restriction rules after exposure.

With modern supportive care most immunised older children recover fully though cough may linger. Mortality is concentrated in young infants; survivors of hypoxic or pulmonary hypertensive crises may need developmental follow-up. Adults return to baseline once paroxysms settle but may report prolonged throat irritation.

Parents often minimise catarrhal symptoms—use a timeline diagram on the whiteboard so they see why NAAT was sent “late” but still useful. For non-English-speaking households employ interpreter phones before discharge teaching on red-flag apnea.

• SpO₂ baseline and with cough clusters; escalate if sustained <92% on room air (adjust threshold per local oxygen policy).
• Apnea count per hour; feeding volume <50% usual for two consecutive feeds triggers review.
• Heart rate and perfusion between paroxysms—tachycardia out of proportion suggests secondary infection.
• Document spell duration and recovery colour—helps consultants judge trajectory.

Worsening spell frequency, new focal chest signs, rising oxygen requirement or falling platelets in a toxic-looking infant should prompt senior review, repeat imaging and broadened antibiotics if bacterial superinfection is suspected. PICU criteria include recurrent apnea needing stimulation, FiO₂ escalation or airway support.

Pre-treatment

Institute droplet isolation, obtain vitals and baseline weight, prepare nasopharyngeal specimen kit before macrolide if policy allows brief delay.

Post-treatment

Confirm first dose given, observe for vomiting within 30 minutes—redose per protocol if entire dose lost. Teach carers gentle bulb suction and when to return.

Education & evaluation

Return precautions written at fifth-grade reading level; evaluate understanding with teach-back on red flags.

These NCLEX-style clinical judgment practice items focus on the nursing priorities for this condition — recognise cues, escalate red flags, take safe action and evaluate outcomes (NCSBN Clinical Judgment Measurement Model) — through Priority FIRST, SATA, deterioration trends, multi-patient triage, ordered response and matrix matching on the topic of pertussis phases, NAAT timing, macrolide stewardship, droplet isolation and neonatal apnea surveillance—mirroring Clinical Judgment Measurement Model reasoning from cue recognition through evaluation of outcomes.